References
- World Health Organization. Progress on Global Access to HIV Antiretroviral Therapy. An Update on “3 by 5”. Geneva: WHO, June 2005.
- UNAIDS. Report on the Global HIV/AIDS Epidemic. WHO, 2006.
- National AIDS Commission. National Estimate of HIV/AIDS in Malawi in 2003. Lilongwe, Malawi, 2003.
- Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004; 364:1236–43.
- van Oosterhout JJ, Bodasing N, Kumwenda JJ, et al. Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Trop Med Int Health 2005; 10:464–70.
- Ministry of Health, Malawi. Treatment of AIDS: Guidelines for the Use of Antiretroviral Therapy in Malawi, 1st edn. Lilongwe, October 2003.
- UNICEF/WHO Technical Consultation. Improving Access to Appropriate Paediatric ARV Formulations. Geneva: WHO, November 2004.
- World Health Organization. Scaling up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach, 2003 revision. Geneva: WHO, 2004.
- Rogerson SR, Gladstone M, Callaghan M, et al. HIV infection among paediatric in-patients in Blantyre, Malawi. Trans R Soc Trop Med Hyg 2004; 98:544–52.
- World Health Organization, UNAIDS, UNICEF. Joint Statement on the Use of Cotrimoxazole as Prophylaxis in HIV Exposed and HIV Infected Children. Geneva: WHO, 2004.
- Eley B, Nuttall J, Davies MA, et al. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents. S Afr Med J 2004; 94:643–6.
- Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d’Ivoire. AIDS 2004; 18:1905–13.
- Barlow-Mosha L, Musoke P, Ajuna P, et al. Early effectiveness of Triomune in HIV-infected Ugandan childreni Third International AIDS Society Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, 2005; abstract WeOa0103.
- World Health Organization. Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children. Geneva: WHO, August 2006
- Walker AS, Mulenga V, Sinyinza F, et al. Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial. J Acquir Immune Defic Syndr 2006; 42:637–45.
- Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics 2002; 109:E25
- Ellis JC, L’Homme RFA, Ewings FM, et al. Nevirapine concentrations in HIV-infected children treated with divided fixed dose combination tablets in Malawi and Zambia. Antivir Ther 2007; 12:253–60.